COVID-19 e câncer: uma revisão extensa

Emerging data postulates that cancer is an important risk factor for disease severity and higher in-hospital mortality amongst patients with COVID-19. From a pathophysiological perspective, COVID-19 induces overproduction of inflammatory cytokines, causing systemic inflammation, hypercoagulability, multiple organ dysfunction syndrome. The exact mechanisms associated severe in uncertain. Moreover, the challenge implementing social distancing requiring specific anticancer treatments urged international societies to issue recommendations regarding adoption safety measures reduce transmission optimize treatment during pandemic. We provide extensive review clinical outcomes, prognosis management infection.